All Questions
- Understanding genetic variations and environmental influences that contribute to diseases.
- Identifying the most suitable treatment for each patient.
- Optimizing the use of existing medications to align with each individual's unique genetic makeup.
- Discovering new treatments.
- Advancing therapies and research development.
Preliminary studies have indicated that the following diseases are the most common in the initial sample analysis. More conditions will be identified in future phases as the National Genome Project progresses:
- Hereditary blood disorders: Sickle cell anemia, thalassemia, and others.
- Genetic cancers: Hereditary breast and ovarian cancer.
- Genetic heart diseases: Hypertrophic cardiomyopathy, familial hypercholesterolemia, Brugada syndrome, and others.